This draft Recommendation Statement is based on an Evidence Report that is also available for public comment. The USPSTF makes recommendations about the effectiveness of specific clinical preventive services for patients without related signs or symptoms.
It bases its recommendations on the evidence of both the benefits and harms of the service, and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment.
The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decisionmaking to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
This draft Recommendation Statement is available for comment from February 11 until March 10, 2014, at 5:00 PM ET. You may wish to read the entire Recommendation Statement before you comment. A fact sheet that explains the draft recommendations in plain language is available here.
Draft Recommendation Statement
It is estimated that about 700,000 to 1.4 million persons in the United States have chronic HBV infection ( 1, 2). In the United States, persons considered at high risk for HBV infection include persons from high-prevalence countries, persons who…
Last Updated on January 25, 2020 by HepFree NYC